Breast carcinoma in women under the age of 50: Relationship between p53 immunostaining, tumour grade, and axillary lymph node status

Breast Cancer Research and Treatment

Volumn 49, Issue 1, 1998, Pages 35-39

  Pratap, R ^a   Shousha, S ^a,b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Axillary lymph node; Breast carcimoma; Breast screening; Metastasis; p53; Tumour grade

Indexed keywords

AVIDIN; BIOTIN; MONOCLONAL ANTIBODY; PEROXIDASE; PROTEIN P53;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER GRADING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031838145     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005993220824     Document Type: Article

References (14)

1. Lee CG, McCormick B, Mazumdar M, Vetto B, Borgen PI: Infiltrating breast carcinoma in patients age 30 years and younger: long term outcome for life, relapse, and second primary tumours. Int J Rad One Biol Phys 23: 969-975, 1992
2. Calle EE, Martin IM, Thun MJ, Mircale HI, Heath CW Jr: Family history, age and risk of fatal breast cancer. Am J Epidemiol 138: 675-681, 1993
3. De La Rochefordiere A, Asselain B, Campana F, Scholl SM, Fenton J, Vilcoq JR, Durand J-C, Pouillart P, Magdelenat H, Fourquet A: Age as a prognostic factor in premenopausal breast carcinoma. Lancet 341: 1039-1043, 1993
4. Iwaya K, Tsuda H, Hiraide H, Tanaki K, Tamakuma S, Fukutomi T, Mukai K, Hirohashi S: Nuclear p53 immunoreaction associated with poor prognosis in breast cancer. Jap J Cancer Res 82: 835-840, 1991
5. Isola J, Viskorpi T, Holli K, Kallioniemi O-P: Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J Nat Cancer Inst 84: 1109-1114, 1992
6. Thor AD, Moore DH II, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen L-C, Mayall BH, Smith HS: Accumulation of mutant p53 tumor suppressor gene protein: an index of prognosis in breast carcinoma. J Nat Cancer Inst 84: 845-855, 1992
7. Allred DC, Clark GM, Elledge R, Fuqua SAW, Brown RW, Chamness GC, Osborne CK, McGuire WL: Association of p53 protein expression with tumour cell proliferation rate and clinical outcome in node-negative breast cancer. J Nat Cancer Inst 85: 200-206, 1993
8. Barnes DM, Dublin EA, Fisher CJ, Levison DA, Millis RR: Immunohistochemical detection of p53 protein in mammary carcinoma: an important new indicator of prognosis? Hum Pathol 24: 469-476, 1993
9. Norton AJ, Jordan S, Yeomans P: Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J Pathol 173: 371-379, 1994
10. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. 1. The value of histological grade in breast cancer: experience from a large study with long-term follow up. Histopathology 19: 403-410, 1991
11. Elledge RM, Clark GM, Fuqua SAW, Yu Y-Y, Allred DC: p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer. Cancer Res 54: 3752-3757, 1994
12. Stenmark-Askmalm M, Stal O, Olsen K, Nordenskjold B, South-East Sweden Breast Cancer Group: p53 as a prognostic factor in stage I breast cancer. Br J Cancer 72: 715-716, 1995
13. Seshadri R, Leong A S-Y, McCaul K, Firgaira FA, Setlur V, Horsfall DJ: Relationship between p53 gene abnormalities and other tumor characteristics in breast-cancer prognosis. Int J Cancer 69: 135-141, 1996
14. Glebov OK, McKenzie KE, White CA, Sukumar S: Frequent p53 gene mutations and novel alleles in familial breast cancer. Cancer Res 54: 3703-3709, 1994